Global Glp 1 Receptor Agonists Obesity Drugs Market Market Size in USD Billion GLP-1 Receptor Agonists Obesity Drugs Market Size The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032 , at a CAGR of 16.21% during the forecast period The market growth is primarily driven by the increasing need for secure, transparent, and tamper-proof systems to manage sensitive healthcare data, billing processes, and patient records across diverse stakeholders In addition, the rising adoption of blockchain technology by healthcare providers, insurers, and pharmaceutical companies to streamline operations, enhance data integrity, and mitigate fraud is propelling market expansion
Rather than relying on more aggressive treatments, these ingredients tend to focus on soothing, hydration, and brightening, reflecting K-beautys broader emphasis on prevention and consistent, long-term care, says Dr
(3) Increased skin thickness, firmness, and elasticity A 12-week trial with 71 women showed that GHK-Cu increased skin firmness, improved clarity, and reduced fine lines
How Benadryl Works in the Body Benadryl works by blocking histamine, a substance in your body that can cause allergic reactions like itching, sneezing, and watery eyes